263 related articles for article (PubMed ID: 36524848)
21. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
[TBL] [Abstract][Full Text] [Related]
22. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer.
Wu W; Wang X; Le W; Lu C; Li H; Zhu Y; Chen X; An W; Xu C; Wu Q; Wang L
Front Immunol; 2022; 13():1001297. PubMed ID: 36700224
[TBL] [Abstract][Full Text] [Related]
23. Contribution of prognostic ferroptosis-related subtypes classification and hub genes of sepsis.
Ding N; Xu X; Wang Y; Li H; Cao Y; Zheng L
Transpl Immunol; 2022 Oct; 74():101660. PubMed ID: 35787932
[TBL] [Abstract][Full Text] [Related]
24. Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors.
Ma VT; Su CT; Hu M; Taylor JMG; Daignault-Newton S; Kellezi O; Dahl MN; Shah MA; Erickson S; Lora J; Hamasha R; Ali A; Yancey S; Kiros L; Balicki HM; Winfield DC; Green MD; Alva AS
Urol Oncol; 2021 Jul; 39(7):437.e1-437.e9. PubMed ID: 33495117
[TBL] [Abstract][Full Text] [Related]
25. Identification of molecular subtypes of ischaemic stroke based on immune-related genes and weighted co-expression network analysis.
Wei D; Chen X; Xu J; He W
IET Syst Biol; 2023 Apr; 17(2):58-69. PubMed ID: 36802116
[TBL] [Abstract][Full Text] [Related]
26. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
Rui X; Shao S; Wang L; Leng J
BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
[TBL] [Abstract][Full Text] [Related]
27. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
28. [MiR-4772 modulates tumor immune microenvironment by regulating immune- related genes in ovarian cancer].
Zhao A; Su Y; Fu D
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1638-1645. PubMed ID: 36504056
[TBL] [Abstract][Full Text] [Related]
29. IP-score correlated to endogenous tumour antigen peptide processing: A candidate clinical response score algorithm of immune checkpoint inhibitors therapy in multiple cohorts.
Wang Y; Yan K; Guo Y; Lu Y; Su H; Li H
Front Immunol; 2022; 13():1085491. PubMed ID: 36700205
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis.
Chen X; Wang J; Peng X; Liu K; Zhang C; Zeng X; Lai Y
Medicine (Baltimore); 2020 Apr; 99(14):e19628. PubMed ID: 32243390
[TBL] [Abstract][Full Text] [Related]
31. Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer.
Li M; Zhang J; Zhang Z; Qian Y; Qu W; Jiang Z; Zhao B
Front Endocrinol (Lausanne); 2022; 13():721569. PubMed ID: 35185791
[TBL] [Abstract][Full Text] [Related]
32. Screening and identification of potential hub genes and immune cell infiltration in the synovial tissue of rheumatoid arthritis by bioinformatic approach.
Feng ZW; Tang YC; Sheng XY; Wang SH; Wang YB; Liu ZC; Liu JM; Geng B; Xia YY
Heliyon; 2023 Jan; 9(1):e12799. PubMed ID: 36699262
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Chen X; Cao K
Cancer Med; 2021 Dec; 10(23):8693-8707. PubMed ID: 34668665
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of programmed cell death-ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta-analysis.
Ouyang Y; Liu W; Zhang N; Yang X; Li J; Long S
Cancer Med; 2021 Oct; 10(20):7021-7039. PubMed ID: 34423578
[TBL] [Abstract][Full Text] [Related]
36. Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy.
Li Z; Duan Y; Ke Q; Wang M; Cen H; Zhu X
Front Genet; 2022; 13():1000460. PubMed ID: 36276947
[No Abstract] [Full Text] [Related]
37. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile.
Peng M
Front Immunol; 2022; 13():970885. PubMed ID: 36003383
[TBL] [Abstract][Full Text] [Related]
38. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification.
Bi Y; Jing Y; Guo L
Front Genet; 2022; 13():1017551. PubMed ID: 36263426
[No Abstract] [Full Text] [Related]
39. Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy.
Liao Y; He D; Wen F
Immunogenetics; 2021 Oct; 73(5):369-380. PubMed ID: 34302518
[TBL] [Abstract][Full Text] [Related]
40. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
